email page print page rss feed
Personalizing Medicine
Personalizing Medicine

The U.S healthcare system is under tremendous stress as a result of unsustainable cost pressures, demographic shifts and the advent of new medical technologies. By personalizing medicine through better understanding of the individual we can improve patient care and greatly increase healthcare productivity. MDV funds entrepreneurs and cross-disciplinary teams focused on biomedical breakthroughs, molecular diagnostics and technology platforms that will deliver on this vision.

OQ_logo.small

On-Q-ity is a next-generation diagnostics company focused on transforming cancer treatment and improving treatment outcomes for cancer patients. The company is developing innovative diagnostics to identify the unique characteristics of an individual's cancer, predicting the response to therapy, and monitoring the progress of treatment.

www.on-q-ity.com

0

PacBio.logo.png

Pacific Biosciences (PacBio) is developing a transformative single-molecule, real-time (SMRT) DNA sequencing platform. PacBio's goal is to commercialize SMRT DNA sequencing technology, eventually enabling sequencing of individual genomes as part of routine medical care. Founded in 2004.

www.pacificbiosciences.com

0

adamas.jpg

Adamas is an emerging pharmaceutical company focused on developing small molecule, Advantaged Therapeutics™ to treat neurological and infectious diseases, including influenza A, the cause of the current flu pandemic. Adamas' approach to pharmaceutical development is to identify and match proven drug mechanisms that can be developed as optimized combination drug therapies to increase safety, efficacy and compliance, thus improving upon the standard of care.

www.adamaspharma.com

0

CardioDX.sized

CardioDx is a molecular diagnostics company that serves cardiologists and their patients by offering clinically validated genomic tests to enhance patient care. These tests will help cardiologists identify patients who will benefit most from advanced cardiovascular therapies and predict risk for developing disease. Founded in 2004.

www.cardiodx.com

0

corventis.jpg

Corventis is focused on improving the care of cardiovascular patients and revolutionizing the treatment of cardiovascular disease by developing truly innovative and clinically meaningful technologies for health care professionals. Founded 2005.

corventismedical.com

0

irhythm_logo.gif

iRhythm strives to ensure that cardiac rhythm monitoring becomes more accessible and available to patients who may be at risk for an abnormal heart rhythm, or an arrhythmia.

www.irhythmtech.com

0

navilogo_small_color.jpg

Navigenics, Inc. specializes in personalized consumer health and wellness services, with the overall goal of improving health outcomes in individuals across the population. Navigenics educates and empowers customers with knowledge of their genetic predispositions, and then motivates them to act on the information to prevent the onset of disease, achieve earlier diagnosis, appropriately manage disease, or otherwise lessen its impact.

www.navigenics.com

0

raindance.bmp

RainDance Technologies™ is a provider of innovative droplet-based solutions that accelerate human health and disease research. The simplicity and speed of its new technology inspire researchers to rethink the way they design experiments and approach discovery. Its core RainStorm™ microfluidics technology produces 10 million picoliter-volume droplets per hour. Each droplet is the functional equivalent of a test tube and can contain a single molecule, reaction, or cell. The company empowers the scientist with solutions that minimize experimental error, provide simple, high-speed workflow, and generate accurate measurements. Founded in 2004.

www.raindancetechnologies.com/

0

tethys.size

Tethys Bioscience is dedicated to the discovery, development and commercialization of novel biological markers - biomarkers - that provide a practical tool to address the growing global challenge of chronic metabolic diseases such as diabetes. Founded in 2002

www.tethysbio.com

0

Vitapath_logo.png

VitaPath Genetics develops molecular diagnostics to help patients and their doctors correct genetic mutations that can result in serious, but preventable, disease. The company's initial focus is a validated genetic test for spina bifida, a common birth defect that can be avoided with high dose folic acid therapy under the care of a physician.

www.vpgenetics.com

0

See more portfolio companies.

Who Should I Contact?
See our Submitting A Plan section for details on sending us your business plan. Then review our Team section to determine the most appropriate partner to receive your information.

Related Materials

President's Council of Advisors on Science and Technology

See more Related Materials.

^ Top

Affiliations

Health 2.0

NVCA

California Institute for Regenerative Medicine

Caltech Division of Biology Advisory Council

See more Affiliations.

^ Top

News

BusinessWire, February 3, 2010
RainDance Technologies Appoints S. Roopom Banerjee as President and Chief Executive Officer

BusinessWire, February 3, 2010
Navigenics Raises $18 Million in Series C Financing

Start Up Magazine, February 1, 2010
On-Q-ity Profile

Genome Web, January 26, 2010
People in the News

See more MDV/Portfolio Company Coverage.

^ Top

Speaking engagements

March 24, 2010
Geoffrey Moore
University of San Francisco International Business Plan Competition
Location: San Francisco, CA

March 24, 2010
Michael Goldberg
CTIA Wireless 2010
Location: Las Vegas, NV

June 14, 2010
Rowan Chapman
ILSI Biomed Conference
Panel: Perspectives on Personalized Medicine

See more MDV Speaking Engagements.

^ Top